High-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages II-III esophageal cancer. [electronic resource]
Producer: 20140714Description: 534-40 p. digitalISSN:- 1465-3621
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Chemoradiotherapy -- adverse effects
- Cisplatin -- administration & dosage
- Disease-Free Survival
- Docetaxel
- Dose-Response Relationship, Radiation
- Drug Administration Schedule
- Esophageal Neoplasms -- drug therapy
- Esophageal Stenosis -- etiology
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Humans
- Incidence
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplasm Staging
- Platinum Compounds -- administration & dosage
- Prognosis
- Radiation Pneumonitis -- etiology
- Radiotherapy Dosage
- Retrospective Studies
- Risk Factors
- Taxoids -- administration & dosage
- Treatment Failure
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.